argenx
Biotechnology
argenx is a biotechnology company committed to improving the lives of patients through immunology innovation. The company focuses on developing novel antibody-based therapies to treat severe autoimmune diseases. Using a collaborative approach with pioneering scientists and academic partners, argenx accelerates the discovery of therapeutic antibodies that target specific disease pathways. The company's proprietary products, such as efgartigimod, are aimed at treating diseases where IgG antibodies are pathogenic. Argenx emphasizes innovation, science of collaboration, and patient-centric approaches in its mission to deliver life-changing medical solutions.
1001 - 5000 employees
Founded 2008
🧬 Biotechnology
Director, Investor Relations – Europe
Job not on LinkedIn
November 14
argenx
Biotechnology
argenx is a biotechnology company committed to improving the lives of patients through immunology innovation. The company focuses on developing novel antibody-based therapies to treat severe autoimmune diseases. Using a collaborative approach with pioneering scientists and academic partners, argenx accelerates the discovery of therapeutic antibodies that target specific disease pathways. The company's proprietary products, such as efgartigimod, are aimed at treating diseases where IgG antibodies are pathogenic. Argenx emphasizes innovation, science of collaboration, and patient-centric approaches in its mission to deliver life-changing medical solutions.
1001 - 5000 employees
Founded 2008
🧬 Biotechnology
📋 Description
• Develop and implement near-term and comprehensive long-term investor relations strategy with a focus on Europe and aligned with global investor relations strategy • Maintain broad-based knowledge of argenx’s research and development pipeline and business strategies to represent company to the investment community • Collaborate with R&D and discovery teams in Ghent office to integrate key messages from pipeline programs, including early-stage assets, into IR narrative • Serve as a primary liaison to investment community in Europe and additional ex-US regions, including Middle East and Australia • Develop and implement core IR materials, including corporate presentations, press releases, conference call scripts and Q&A documents • Lead and manage corporate participation at European investor conferences, non-deal roadshows and assorted investor and analyst meetings • Contribute to development of the Annual Report and ESG strategy in partnership with legal and finance teams
🎯 Requirements
• 10+ years’ IR experience or similar role in the biotech or pharma space • Bachelor’s degree or higher in related field • Excellent interpersonal, verbal and written communications skills • Experience working and leading in a global workplace, driving strong teamwork and collaboration • Strong track record of building relationships with investor and analyst community • Experience developing executive level communications and engaging directly with senior management with minimal oversight • Highly proficient in Microsoft Office (Word, Excel, PowerPoint, Outlook) • Experience managing external agencies and budget • Candidates must have an excellent level of English communication skills, both verbal and written • Must exhibit argenx core values: innovation, excellence, empowerment, humility and co-creation • Willing to travel up to min. 30% of the time globally
🏖️ Benefits
• Inclusive environment • Equal consideration for employment without discrimination
Apply Now